(NP (NP (NN Goal)) (: :) (S (NP (NP (JJ Squamous) (NN cell) (NN carcinoma)) (PP (IN of) (NP (NN cervix)))) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ prevalent)) (NN cancer)) (ADVP (NN worldwide)) (PP (IN in) (NP (NNS females)))))))) (. .))
(S (ADVP (RB Traditionally)) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ indispensable)) (NN diagnosis)) (PP (IN of) (NP (NN cervix) (JJ squamous) (NN carcinoma)))) (VP (VBZ is) (NP (NP (JJ histopathological) (NN assessment)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN achieved) (PP (IN under) (NP (NN microscope))) (PP (IN by) (NP (NN pathologist))))))))) (. .))
(S (S (ADVP (RB However)) (, ,) (S (NP (NP (JJ human) (NN evaluation)) (PP (IN of) (NP (NN pathology) (NN slide)))) (VP (VBZ is) (ADJP (RB highly) (VBG depending) (PP (IN on) (NP (NP (DT the) (NN experience)) (PP (IN of) (NP (NN pathologist))))))))) (, ,) (S (ADVP (RB thus)) (NP (JJ big) (ADJP (JJ inter-) (CC and) (JJ intra-observer)) (NN variability)) (VP (NNS exists))) (. .))
(S (NP (NNP Digital) (NN pathology)) (, ,) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ deep) (VBG learning))))) (VP (VBZ provides) (NP (DT an) (NN opportunity) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (NN objectivity) (CC and) (NN efficiency)) (PP (IN of) (NP (JJ histopathologic) (NN slide) (NN analysis))))))))) (. .))
(NP (NP (NNS Methods)) (: :) (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD obtained) (NP (CD 800) (ADJP (NN haematoxylin) (CC and) (NN eosin) (VBD stained)) (NNS slides)) (PP (IN from) (NP (NP (CD 300) (NNS patients)) (VP (VBD suffered) (PP (IN from) (NP (NN cervix) (JJ squamous) (NN carcinoma)))))))) (. .))
(S (PP (VBN Based) (PP (IN on) (NP (NP (NN information)) (PP (IN from) (NP (NP (JJ morphological) (NN heterogeneity)) (PP (IN in) (NP (NP (DT the) (NN tumor)) (CC and) (NP (PRP$ its) (JJ adjacent) (NN area))))))))) (, ,) (NP (PRP we)) (VP (VBD established) (NP (NP (JJ deep) (NN learning) (NNS models)) (VP (VBG using) (NP (NP (JJ popular) (NN convolution) (JJ neural) (NN network) (NNS architectures)) (PRN (-LRB- -LRB-) (NP (NP (JJ inception-v3)) (, ,) (NP (NNP InceptionResnet-v2)) (CC and) (NP (NNP Resnet50))) (-RRB- -RRB-)))))) (. .))
(S (ADVP (RB Then)) (NP (VB random) (NN forest)) (VP (VBD was) (VP (VBN introduced) (S (VP (TO to) (VP (VB feature) (NP (NP (NNS extractions)) (CC and) (NP (JJ slide-based) (NN classification)))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (NP (DT The) (JJ overall) (NN performance)) (PP (IN of) (NP (PRP$ our) (VBN proposed) (NNS models))) (PP (IN on) (NP (JJ slide-based) (NN tumor) (NN discrimination)))) (VP (VBD were) (ADJP (JJ outstanding)) (PP (IN with) (NP (NP (DT an) (NNP AUC) (NNS scores)) (ADJP (VBD >) (NP (CD 0.94))))))) (. .))
(S (IN While) (, ,) (NP (NP (NN location) (NNS identifications)) (PP (IN of) (NP (NNS lesions))) (PP (IN in) (NP (JJ whole) (NN slide) (NNS images)))) (VP (VBD were) (ADJP (JJ mediocre)) (PRN (-LRB- -LRB-) (NP (NP (NNP FROC) (VBZ scores)) (NNP >) (NP (CD 0.52))) (-RRB- -RRB-)) (NP (NP (NN duo)) (PP (TO to) (NP (NP (DT the) (JJ extreme) (NN complexity)) (PP (IN of) (NP (NN tumor) (NNS tissues))))))) (. .))
(NP (NP (NN Conclusion)) (: :) (S (PP (IN For) (NP (DT the) (JJ first) (NN time))) (, ,) (NP (PRP$ our) (NN analysis) (NN workflow)) (VP (VBD highlighted) (NP (NP (DT a) (JJ quantitative) (JJ visual-based) (NN slide) (NN analysis)) (PP (IN of) (NP (NN cervix) (JJ squamous) (NN carcinoma)))))) (. .))
(NP (NP (NN Significance)) (: :) (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (NP (NP (DT a) (NN pathway)) (SBAR (S (VP (TO to) (VP (VP (VB assist) (NP (NN pathologist))) (CC and) (VP (VB accelerate) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NNS patients))))) (PP (IN by) (S (VP (VBG utilizing) (NP (JJ new) (JJ computational) (NNS approaches)))))))))))) (. .))
